Culper Research takes short position in Acadia Pharma
By Thomson ReutersFeb 15, 2024 | 10:35 AM
(Reuters) – Culper Research said on Thursday it has taken a short position on Acadia Pharmaceuticals’ stock.
Shares of the company fell 4% to $24.6 after the news.
(Reporting by Pratik Jain in Bengaluru; Editing by Shilpi Majumdar)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.